120 related articles for article (PubMed ID: 20460925)
1. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.
del Campo JA; López RA; Romero-Gómez M
Dig Dis; 2010; 28(1):285-93. PubMed ID: 20460925
[TBL] [Abstract][Full Text] [Related]
2. Hepatic steatosis and hepatitis C: Still unhappy bedfellows?
Hwang SJ; Lee SD
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():96-101. PubMed ID: 21199519
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
Mihm S
Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment.
Harrison SA
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970
[TBL] [Abstract][Full Text] [Related]
5. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
Negro F; Clément S
J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
[TBL] [Abstract][Full Text] [Related]
6. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
[TBL] [Abstract][Full Text] [Related]
8. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C and metabolic syndrome].
Aparcero López R; Campo JA; Romero-Gómez M
Gastroenterol Hepatol; 2010; 33(7):530-40. PubMed ID: 20206412
[TBL] [Abstract][Full Text] [Related]
11. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
Negro F
J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
[TBL] [Abstract][Full Text] [Related]
12. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
13. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
17. Impact of host insulin resistance on fibrosis and response to interferon in chronic hepatitis C.
Moţa M; Popa S; Mota E; Diaconescu I; Gheorghiţoiu I; Panduru M
Rom J Intern Med; 2008; 46(2):105-12. PubMed ID: 19284081
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications.
Hung CH; Lee CM; Lu SN
Expert Rev Anti Infect Ther; 2011 May; 9(5):525-33. PubMed ID: 21609264
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.
Dai CY; Huang JF; Hsieh MY; Chuang WL; Yu ML
Gut; 2010 Mar; 59(3):418. PubMed ID: 20207653
[No Abstract] [Full Text] [Related]
20. Review article: hepatitis C virus-associated steatosis--pathogenic mechanisms and clinical implications.
Adinolfi LE; Durante-Mangoni E; Zampino R; Ruggiero G
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():52-5. PubMed ID: 16225474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
